Limba
|
S-Ruxolitinib is the chirality of INCB018424, which is the first potent, selective, JAK1/2inhibitor to enter the clinic with IC50of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3. Phase 3.
Price | 21.766,00 RON (preturile sunt fara TVA) |
---|---|
Description |
S-Ruxolitinib is the chirality of INCB018424, which is the first potent, selective, JAK1/2inhibitor to enter the clinic with IC50of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3. Phase 3. |